International Journal of Otolaryngology and Head & Neck Surgery

Volume 10, Issue 5 (September 2021)

ISSN Print: 2168-5452   ISSN Online: 2168-5460

Google-based Impact Factor: 0.46  Citations  

Dexamethasone’s Effect on Post-Rhinoplasty Periorbital Edema

HTML  XML Download Download as PDF (Size: 389KB)  PP. 419-425  
DOI: 10.4236/ijohns.2021.105038    685 Downloads   3,269 Views  
Author(s)

ABSTRACT

Introduction: The efficacy of dexamethasone in reducing periorbital edema and ecchymosis following rhinoplasty was investigated in a double-blind, randomized trial. Materials & Methods: The study comprised fifty-four rhinoplasty patients who underwent open rhinoplasty surgery with tip modification, hump excision, and bilateral osteotomy and were divided into three groups: Group one: 18 patients: a single dosage of 8 mg dexamethasone given at the start of the procedure. Group two: 18 patients: three 8 mg dexamethasone doses given at the start of the procedure, then 24 and 48 hours afterwards. Group 3: a control group of 18 patients who were not given any medication. Result: In comparison to control group 3, there was a significant reduction in periorbital edema and ecchymosis in groups l and 2. Group 2 had less periorbital edema and ecchymosis at the end of the first postoperative week than group 1. Conclusion: Edema and ecchymosis were significantly reduced with dexamethasone administration in rhinoplasty with osteotomy. Use of three doses of dexamethasone can reduce edema and ecchymosis after rhinoplasty more than the single dose treatment during the first postoperative week.

Share and Cite:

Merza, H. (2021) Dexamethasone’s Effect on Post-Rhinoplasty Periorbital Edema. International Journal of Otolaryngology and Head & Neck Surgery, 10, 419-425. doi: 10.4236/ijohns.2021.105038.

Cited by

No relevant information.

Copyright © 2025 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.